Status:
COMPLETED
The Norwegian Vitamin Trial (NORVIT)
Lead Sponsor:
University of Tromso
Collaborating Sponsors:
The Research Council of Norway
The Council on Health and Rehabilitation, Norway
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
30-85 years
Phase:
NA
Brief Summary
The purpose of this study is to examine whether the lowering of blood homocysteine levels by treatment with B vitamins can prevent cardiovascular disease
Detailed Description
Observational studies have demonstrated that elevated levels of plasma total homocysteine is a risk factor for cardiovascular disease. The purpose of this trial is to evaluate the efficacy of homocyst...
Eligibility Criteria
Inclusion
- Acute myocardial infarction within 7 days prior to randomization
- Men and women aged 30-85 years
- Written informed consent
Exclusion
- Coexisting disease that shortens expected survival to less than 4 years
- Ongoing treatment with B vitamins
- Expected poor compliance
Key Trial Info
Start Date :
December 1 1998
Trial Type :
INTERVENTIONAL
End Date :
March 1 2004
Estimated Enrollment :
3750 Patients enrolled
Trial Details
Trial ID
NCT00266487
Start Date
December 1 1998
End Date
March 1 2004
Last Update
May 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Community Medicine, University of Tromsø
Tromsø, Norway, N-9037